Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride

Topics: 

Citation
Patorno E, et al. Diabetes Care 2019. dc190069.